SCHEMBL7083364

SCHEMBL7083364

CC(C)CN(Cc1cccc(C(=N)NO)c1)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.51
GRIN3B O60391 1/20 0.51
GRIN1 Q05586 1/20 0.51
GRIN2A Q12879 1/20 0.51
GRIN2B Q13224 1/20 0.51
GRIN2C Q14957 1/20 0.51
GRIN3A Q8TCU5 1/20 0.51
HDAC1 Q13547 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
PTGES O14684 5/20 0.45
MEP1B Q16820 10/20 0.44
MEP1A Q16819 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
PPARG P37231 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7087160 0.87 MEP1B (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7083688 0.86 PPARG (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7084315 0.85 GRIN2D (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7087197 0.84 HDAC1 (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7086987 0.82 MEN1 (0.51) PTGESMEP1BMEP1APPARG
SCHEMBL6565036 0.82 GRIN2D (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7083256 0.81 HDAC1 (0.55) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7086989 0.81 HDAC1 (0.51) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7087183 0.80 MEN1 (0.54) HDAC1HDAC6MEP1BMEP1A
SCHEMBL7090040 0.79 MEP1B (0.43) PTGESMEP1BMEP1APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa MERCK PATENT GMBH (DE) 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199698-A1 Carbamic acid esters as inhibitors of factor xa F11, F12, F13A1 GRIN2D 3815/4885GRIN3B 3753/4885GRIN1 1030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.